Immune Response After Leptospirosis Infection
SERO7LEPTO
Serological Response in Patients Infected by Leptospirosis 1 to 7 Years Earlier
1 other identifier
observational
175
0 countries
N/A
Brief Summary
Leptospirosis is a zoonotic infection induced by pathogen bacteria (genus: Leptospira) growing in water polluted by animal fluids. Due to its 10 fold occurence in French overseas aera, and especially in Reunion Island, as compared to metropoly, it is considered as a major public health issue. An important inter-individual variability in humoral immune response suggests that vaccination should be recommended in exposed subjects. This cohort study aimed to determine if subjects that have been infected by leptospirosis for 1 to 7 years still remain immunized, and then do not need vaccination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2016
CompletedFirst Posted
Study publicly available on registry
September 13, 2016
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedSeptember 13, 2016
September 1, 2016
1.2 years
September 8, 2016
September 8, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Leptospirosis immunization assessed by serum immunoglobulin
Humoral immune response will be measured in serum cured-subjects using micro-agglutination test
1-7 years after leptospirosis infection
Secondary Outcomes (2)
rate of still-immunized patients
1-7 years after leptospirosis infection
comparison of 3 diagnosis method for leptospirosis
1-7 years after leptospirosis infection
Interventions
Blood sampling
Eligibility Criteria
Leptospirosis-cured subjects that have undergone leptospirosis
You may qualify if:
- Subjects diagnosed for leptospirosis by polymerase chain reaction measured in Reunion Island Hospital between 209-2015
- with social security issue
You may not qualify if:
- Leptospirosis diagnosis not confirmed by polymerase chain reaction
- subject exhibiting immunodepressive status (cancers, transplantation, immune deficit, blood disorders)
- under medication: corticoids, immunosuppressor, chemiotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de la Réunionlead
- Institut Pasteurcollaborator
Biospecimen
Plasma
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
NICOLAS TRAVERSIER, MD
CHU DE LA REUNION
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2016
First Posted
September 13, 2016
Study Start
October 1, 2016
Primary Completion
December 1, 2017
Study Completion
September 1, 2018
Last Updated
September 13, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share